Advertisement

Metformin Oral Tablets

[07 June 2012]

Products Affected - Description

Metformin tablets, Amneal
500 mg extended release, 90 count (NDC 53746-0178-90) - discontinued 
1000 mg, 500 count (NDC 65162-0177-50)

Metformin tablets, Mutual Pharmaceuticals
500 mg, 100 count (NDC 53489-0467-01) - discontinued
500 mg, 500 count (NDC 53489-0467-05) - discontinued
500 mg, 1000 count (NDC 53489-0467-10) - discontinued
850 mg, 100 count (NDC 53489-0468-01) - discontinued
850 mg, 500 count (NDC 53489-0468-05) - discontinued
850 mg, 1000 count (NDC 53489-0468-10) - discontinued
1000 mg, 100 count (NDC 53489-0469-01) - discontinued
1000 mg, 500 count (NDC 53489-0469-05) - discontinued
1000 mg, 1000 count (NDC 53489-0469-10) - discontinued   

Metformin tablets, Mylan
500 mg, 100 count (NDC 00378-0234-01) - discontinued
850 mg, 100 count (NDC 00378-0240-01) - discontinued
750 mg extended release, 100 count (NDC 00378-0350-01) - discontinued
500 mg, 500 count (NDC 00378-0234-05) - discontinued
500 mg extended release, 100 count (NDC 00378-0352-01) - discontinued
500 mg extended release, 500 count (NDC 00378-0352-05) - discontinued
1000 mg, 100 count (NDC 00378-0244-01) - discontinued

Metformin tablets, Ranbaxy
500 mg, 100 count (NDC 63304-0860-01) - discontinued
500 mg, 500 count (NDC 63304-0860-05) - discontinued
750 mg, 100 count (NDC 63304-0767-01) - discontinued

Metformin tablets, Sandoz
850 mg, 12 x 60 package (NDC 00781-5051-61)
1000 mg, 12 x 60 package (NDC 00781-5052-61)

Metformin tablets, Teva
500 mg, 100 count, unit dose (NDC 00093-1048-93) - discontinued
850 mg, 100 count, unit dose (NDC 00093-1049-93) - discontinued
1000 mg, 100 count, unit dose (NDC 00093-7214-93) - discontinued   

Metformin tablets, UDL
850 mg, 100 count, unit-dose (NDC 51079-0973-20) - discontinued
500 mg, 25 count, unit-dose (NDC 51079-0972-19) - discontinued
500 mg, 100 count, unit-dose (NDC 51079-0972-20) - discontinued 
500 mg, 300 count, unit-dose (NDC 51079-0972-56) - discontinued
 
Metformin tablets, Watson
850 mg, 1000 count (NDC 62037-0675-10) - discontinued
1000 mg, 1000 count (NDC 62037-0676-10) - discontinued

Reason for the Shortage

  • Apotex had metformin products unavailable due to an FDA import ban. Metformin immediate-release tablets are not being currently marketed at this time.
  • Sandoz has metformin products on shortage due to manufacturing delays.
  • Ranbaxy has all discontinued metformin oral tablets.
  • Mutual discontinued all metformin products.
  • Mylan has discontinued several metformin presentations.
  • Teva discontinued metformin unit dose presentations in early-August, 2011.
  • UDL discontinued metformin 500 mg 100 unit dose presentation in late-July, 2011.
  • Watson discontinued metformin 850 mg and 1000 mg presentations.

Available Products

Metformin tablets, Amneal
500 mg, 100 count (NDC 65162-0175-10)
500 mg, 500 count (NDC 65162-0175-50)
500 mg, 1000 count (NDC 65162-0175-11)
850 mg, 100 count (NDC 65162-0174-10)
850 mg, 500 count (NDC 65162-0174-50)
850 mg, 1000 count (NDC 65162-0174-11)
1000 mg, 100 count (NDC 65162-0177-10)
1000 mg, 1000 count (NDC 65162-0177-11)
500 mg extended release, 100 count (NDC 53746-0178-01)
500 mg extended release, 500 count (NDC 53746-0178-05)
750 mg extended release, 100 count (NDC 53746-0179-01)
 
Metformin tablets, Apotex
500 mg extended release, 100 count (NDC 60505-0260-01)
500 mg extended release, 500 count (NDC 60505-0260-02)
750 mg extended release, 100 count (NDC 60505-1329-01)

Metformin tablets, Aurobindo
500 mg, 100 count (NDC 65862-0008-01)
500 mg, 500 count (NDC 65862-0008-05)
500 mg, 1000 count (NDC 65862-0008-99)
850 mg, 100 count (NDC 65862-0009-01)
850 mg, 500 count (NDC 65862-0009-05)
1000 mg, 100 count (NDC 65862-0010-01)
1000 mg, 1000 count (NDC 65862-0010-99)

Metformin tablets, Caraco
500 mg, 100 count (NDC 57664-0397-51)
500 mg, 500 count (NDC 57664-0397-53)
500 mg, 1000 count (NDC 57664-0397-58)
850 mg, 100 count (NDC 57664-0435-51)
850 mg, 500 count (NDC 57664-0435-53)
850 mg, 1000 count (NDC 57664-0435-58)
1000 mg, 100 count (NDC 57664-0474-51)
1000 mg, 500 count (NDC 57664-0474-53)
1000 mg, 1000 count (NDC 57664-0474-58)
500 mg extended release, 100 count (NDC 62756-0142-01)
500 mg extended release, 500 count (NDC 62756-0142-02)
750 mg extended release, 100 count (NDC 62756-0143-01)

Metformin tablets, Glenmark
500 mg, 90 count (NDC 68462-0159-90)
500 mg, 100 count (NDC 68462-0159-01)
500 mg, 500 count (NDC 68462-0159-05)
500 mg, 1000 count (NDC 68462-0159-10)
850 mg, 90 count (NDC 68462-0160-90)
850 mg, 100 count (NDC 68462-0160-01)
850 mg, 500 count (NDC 68462-0160-05)
850 mg, 1000 count (NDC 68462-0160-10)
1000 mg, 90 count (NDC 68462-0161-90)
1000 mg, 100 count (NDC 68462-0161-01)
1000 mg, 500 count (NDC 68462-0161-05)
1000 mg, 1000 count (NDC 68462-0161-10)
 
Metformin tablets, Major
500 mg, 100 count unit-dose (NDC 00904-6090-61)
850 mg, 100 count unit-dose (NDC 00904-6091-61)
1000 mg, 100 count unit-dose (NDC 00904-6092-61)
500 mg extended release, 100 count unit-dose (NDC 00904-6107-61)
750 mg extended release, 100 count unit-dose (NDC 00904-6108-61)

Metformin tablets, Mylan
500 mg, Blackberry flavor, 500 count (NDC 00378-7185-05)
850 mg, Blackberry flavor, 500 count (NDC 00378-7186-05)
1000 mg, 500 count (NDC 00378-7187-05)

Metformin tablets, UDL
1000 mg, 100 count, unit-dose (NDC 51079-0995-20)

Metformin tablets, Sandoz
500 mg, 100 count (NDC 00781-5050-01)
500 mg, 500 count (NDC 00781-5050-05)
500 mg, 1000 count (NDC 00781-5050-10)
850 mg, 100 count (NDC 00781-5051-01)
850 mg, 500 count (NDC 00781-5051-05)
1000 mg, 100 count (NDC 00781-5052-01)
1000 mg, 500 count (NDC 00781-5052-05)
500 mg extended release, 100 count (NDC 00185-4416-01)
500 mg, 12 x 60 package (NDC 00781-5050-61)

Metformin tablets, Teva
500 mg, 90 count (NDC 00093-1048-98)
500 mg, 100 count (NDC 00093-1048-01)
500 mg, 1000 count (NDC 00093-1048-10)
850 mg, 90 count (NDC 00093-1049-98)
850 mg, 100 count (NDC 00093-1049-01)
850 mg, 1000 count (NDC 00093-1049-10)
1000 mg, 90 count (NDC 00093-7214-98)
1000 mg, 100 count (NDC 00093-7214-01)
1000 mg, 1000 count (NDC 00093-7214-10)
500 mg extended release, 100 count (NDC 00093-7267-01)
500 mg extended release, 1000 count (NDC 00093-7267-10)
750 mg extended release, 100 count (NDC 00093-7212-01)

Metformin tablets, Watson
500 mg extended release, 100 count (NDC 62037-0571-01)
500 mg extended release, 1000 count (NDC 62037-0571-10)
750 mg extended release, 100 count (NDC 62037-0577-01)
750 mg extended release, 1000 count (NDC 62037-0577-10)

Metformin tablets, Zydus
500 mg, 100 count (NDC 68382-0028-01)
500 mg, 500 count (NDC 68382-0028-05)
500 mg, 1000 count (NDC 68382-0028-10)
850 mg, 100 count (NDC 68382-0029-01)
850 mg, 500 count (NDC 68382-0029-05)
850 mg, 1000 count (NDC 68382-0029-10)
1000 mg, 100 count (NDC 68382-0030-01)
1000 mg, 500 count (NDC 68382-0030-05)
1000 mg, 1000 count (NDC 68382-0030-10)

Glucophage tablets, Bristol-Myers Squibb
500 mg, 100 count (NDC 00087-6060-05)
500 mg, 500 count (NDC 00087-6060-05)
850 mg, 100 count (NDC 00087-6070-05)
1000 mg, 100 count (NDC 00087-6071-11)
500 mg XR, 100 count (NDC 00087-6063-13)
750 mg XR, 100 count (NDC 00087-6064-13)

Estimated Resupply Dates

  • The majority of metformin presentations are readily available.
  • Amneal has metformin 1000 mg 500 count tablets on back order and the company cannot estimate a release date.
  • Sandoz has metformin 850 mg and 1000 mg tablets in 12 x 60 package presentations on back order and the company cannot estimate a release date.

Related Shortages

Updated

June 7, 2012; May 24, 2012; May 9, 2012; April 24, 2012; March 30, 2012; February 3, 2012; December 21, 2011; November 29, 2011; October 19, 2011; October 5, 2011; September 21, 2011; August 9, 2011; July 27, 2011; June 28, 2011; June 13, 2011; May 11, 2011; April 28, 2011; April 11, 2011; March 28, 2011; March 14, 2011; February 22, 2011; February 4, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity

Get the latest updates on ASHP's advocacy activity on drug shortages.



In Cooperation With
University of Utah & Novation
Advertisement